GlassScriptPhysician profile
Avelino C Alvarez
NPI 1114097524
$11,426.18
in general payments reported to CMS, 2019-2025
19 companies · $440 in 2025
The $440 reported for 2025 was more than what 92% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $5,844 · 2021: $3,473 · 2022: $861 · 2023: $413 · 2024: $166 · 2025: $440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,019.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,019.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $10,203.04 | 2020-2023 | Dyanavel Xr |
| Collegium Pharmaceutical, INC. | $277.60 | 2025 | Jornay Pm |
| Ironshore Pharmaceuticals INC. | $256.86 | 2019-2024 | Jornay Pm |
| Glaxosmithkline, LLC. | $145.13 | 2019-2025 | Bexsero, Pediarix, Penmenvy |
| Cumberland Pharmaceuticals, INC. | $138.64 | 2019-2025 | Kristalose |
| Pfizer INC. | $68.63 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $66.54 | 2020-2025 | Vaxelis, Vaqta, Gardasil 9 |
| Kyowa Kirin, INC. | $36.57 | 2025 | |
| Supernus Pharmaceuticals, INC. | $35.28 | 2021-2022 | |
| Corium, LLC | $34.04 | 2023-2024 | Azstarys |
| Sanofi Pasteur INC. | $31.05 | 2019-2023 | |
| Seqirus USA INC | $22.30 | 2025 | Flucelvax |
| Nestle Healthcare Nutrition INC. | $22.22 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $18.14 | 2020 | |
| Genentech USA, INC. | $15.73 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $15.60 | 2023 | Immunocap |
| Ars Pharmaceuticals Operations, INC. | $14.17 | 2025 | Neffy |
| Takeda Pharmaceuticals U.S.A., INC. | $13.39 | 2020 | |
| Mission Pharmacal Company | $11.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Avelino Alvarez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.